NCT06347068
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- University of North Carolina Chapel Hill, North Carolina, United States
Clinical trial condition
Resistant Cancer
Explore clinical trials studying Resistant Cancer. Study availability and eligibility vary by location and protocol.
5 public trials
3 recruiting studies
Resistant Cancer trial results
NCT06158139
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, +12 more
- Locations
-
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
NCT05889312
- Conditions
- Acute-Phase Reaction, Cancer, Diagnosis, +7 more
- Locations
-
- Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
Not Yet Recruiting
A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma
NCT07535840
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
Active, Not Recruiting
9-ING-41 in Patients With Advanced Cancers
NCT03678883
- Conditions
- Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- University of California Irvine Health Orange, California, United States